SAN DIEGO – Valeant approaches innovation with the concept “the best idea wins” vs. the approach of other companies that their projects “are better no matter what,” said J. Michael Pearson, chairman and CEO of Valeant Pharmaceuticals, during his plenary talk, here at the Ophthalmology Innovation Summit.Innovation is not created in large companies, he said. Pearson believes that the pathway to innovation is through universities, start-up companies and practicing physicians.
SAN DIEGO – Financial activity in the ophthalmology industry is still robust but appears more like 2013 than the strong growth seen in 2014, according to a speaker here. William J. Link, PhD, managing director of Versant Ventures, expressed optim…
SAN DIEGO — Micro-incisional and minimally invasive glaucoma surgery procedures are gaining wide acceptance with cataract surgeons, according to Eric D. Donnenfeld, MD. In his overview of MIGS at the Ophthalmology Innovation Summit, Donnenfeld said that more surgeons and patients are considering MIGS now because of established safety and improved efficacy in real-world experience compared with initial clinical trials.
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image premature infant eyes in a study to evaluate a potential new method for treating Retinopathy of Prematurity (ROP) using Lucentis™ (ranibizumab). “The use of RetCam in a study of this medical significance demonstrates the growing worldwide acceptance of RetCam for pediatric retinal
BASSANO DEL GRAPPA, Italy — The first two patients implanted with the Argus II retinal prosthesis at a hospital in Camposampiero, Italy, are doing well and are happy with the results, according to Marzio Chizzolini, MD, head of the ophthalmology department.The first implantation of the Argus II (Second Sight Medical Products) was performed in Italy in 2011 at the University of Pisa. Following CE mark approval and entry into the market, the implant has been used in 11 patients in Europe — six in Italy and five in Germany.
Falls are the leading cause of injury-related death and morbidity in older adults, especially those with a chronic eye disease such as glaucoma. To investigate this problem, a multidisciplinary group of researchers has become the first to use virtual r…